BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 22816226)

  • 21. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
    Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
    J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm.
    Gould DJ; Salmans JA; Lassinger BK; Contreras A; Gutierrez C; Bonefas E; Liscum KR; Silberfein EJ
    J Surg Res; 2012 Nov; 178(1):299-303. PubMed ID: 22524977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytologic evaluation of phyllodes tumors as compared to fibroadenomas of the breast.
    Shimizu K; Masawa N; Yamada T; Okamoto K; Kanda K
    Acta Cytol; 1994; 38(6):891-7. PubMed ID: 7992575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
    Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
    Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
    Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
    Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Missed" diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition.
    Yohe S; Yeh IT
    Int J Surg Pathol; 2008 Apr; 16(2):137-42. PubMed ID: 18417670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonality in fibroadenomas with complex histology and phyllodal features.
    Kasami M; Vnencak-Jones CL; Manning S; Dupont WD; Jensen RA; Page DL
    Breast Cancer Res Treat; 1998 Jul; 50(2):185-91. PubMed ID: 9822223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of fibroepithelial tumours of the breast.
    Badhe BA; Iyengar KR; Alva N
    Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
    Resetkova E; Khazai L; Albarracin CT; Arribas E
    Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular (juvenile) fibroadenoma of the breast. A clinico-pathologic and immunohistochemical study of 7 cases].
    Remadi S; Ismail A; Karpuz V; Finci V; Zacharie S; Vassilakos P
    Ann Pathol; 1994; 14(6):392-7. PubMed ID: 7857414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification.
    Chong LY; Cheok PY; Tan WJ; Thike AA; Allen G; Ang MK; Ooi AS; Tan P; Teh BT; Tan PH
    Breast Cancer Res Treat; 2012 Feb; 132(1):143-51. PubMed ID: 21574054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
    Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
    Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
    Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
    AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?
    Kaya R; Pestereli HE; Erdogan G; Gülkesen KH; Karaveli S
    Pathol Oncol Res; 2001; 7(3):213-6. PubMed ID: 11692149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
    Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.